Old Web
English
Sign In
Acemap
>
authorDetail
>
Steven Doleckyj
Steven Doleckyj
Merck & Co.
Osteoporosis
Medicine
Internal medicine
Receptor antagonist
Bone remodeling
2
Papers
36
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety and efficacy of odanacatib in the treatment of men with osteoporosis: a randomised placebo-controlled trial
2015
Eric S. Orwoll
Silvano Adami
Neil Binkley
Roland Chapurlat
Bente Langdahl
Steven Doleckyj
Hilde Giezek
Boyd B. Scott
Arthur C. Santora
Show All
Source
Cite
Save
Citations (2)
A Phase 2, Randomized, Placebo-Controlled, Dose-Ranging Study of the Calcium-Sensing Receptor Antagonist MK-5442 in the Treatment of Postmenopausal Women With Osteoporosis
2014
The Journal of Clinical Endocrinology and Metabolism
Johan Halse
Susan L. Greenspan
Felicia Cosman
Graham Ellis
Arthur C. Santora
Albert Leung
Norman Heyden
Suvajit Samanta
Steven Doleckyj
Elizabeth Rosenberg
Andrew E. Denker
Show All
Source
Cite
Save
Citations (34)
1